2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE, CA
Genelux Corporation Enters $100 Million Sales Agreement with TD Cowen
Investor Presentation
Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock
Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer Trials
Paul Scigalla Resigns as Chief Medical Officer; Jason Litten Appointed
Material disclosure
Annual Report to Security Holders
Announces Pricing of $10.5 Million Underwritten Offering of Common Stock
FY 2025
Q3
Q2
Q1
Amended Annual Report
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Free Writing Prospectus
Amended Notice of Proposed Sale of Securities
Correspondence
Submission Upload